Your browser doesn't support javascript.
loading
Canagliflozin, a sodium glucose co-transporter 2 inhibitor, reduces post-meal glucose excursion in patients with type 2 diabetes by a non-renal mechanism: results of a randomized trial.
Stein, Peter; Berg, Jolene K; Morrow, Linda; Polidori, David; Artis, Eunice; Rusch, Sarah; Vaccaro, Nicole; Devineni, Damayanthi.
  • Stein P; Janssen Research & Development, LLC, Raritan, NJ, USA.
  • Berg JK; DaVita Clinical Research, Minneapolis, MN, USA.
  • Morrow L; Profil Institute for Clinical Research, Inc., Chula Vista, CA, USA.
  • Polidori D; Janssen Research & Development, LLC, San Diego, CA, USA. Electronic address: DPolido1@its.jnj.com.
  • Artis E; Janssen Research & Development, LLC, Raritan, NJ, USA.
  • Rusch S; Janssen Research & Development, Beerse, Belgium.
  • Vaccaro N; Janssen Research & Development, LLC, San Diego, CA, USA.
  • Devineni D; Janssen Research & Development, LLC, Raritan, NJ, USA.
Metabolism ; 63(10): 1296-303, 2014 Oct.
Article en En | MEDLINE | ID: mdl-25110280
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tiofenos / Glucemia / Diabetes Mellitus Tipo 2 / Inhibidores del Cotransportador de Sodio-Glucosa 2 / Glucosa / Glucósidos / Riñón Tipo de estudio: Clinical_trials Límite: Female / Humans / Male / Middle aged Idioma: En Año: 2014 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tiofenos / Glucemia / Diabetes Mellitus Tipo 2 / Inhibidores del Cotransportador de Sodio-Glucosa 2 / Glucosa / Glucósidos / Riñón Tipo de estudio: Clinical_trials Límite: Female / Humans / Male / Middle aged Idioma: En Año: 2014 Tipo del documento: Article